Effectiveness of an online-intervention for patients with anxiety disorder after an inpatient/day clinic stay: a randomized controlled trial

Not Applicable

• Conditions: F40; F41; Phobic anxiety disorders; Other anxiety disorders

• Registration Number: DRKS00025808
• Lead Sponsor: niversitätsklinikum Hamburg-Eppendorf, AG für Angst- und Zwangsstörungen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-07-09
• Study Completion: 2023-12-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

• Presence of a diagnosis of an anxiety disorder (ICD-10 criteria, assessment by the treating psychologists/doctors)
• consent to participate in study (informed consent)
• A previous inpatient- or outpatient-treatment of at least one week
• Minimum Age: 18 Years
• Maximum Age: 80 Years
• willingness to participate in Novego anxiety and four online assessments
• ability to provide informed consent
• sufficient understanding of the German language

Exclusion Criteria

• Absence of a diagnosis of an anxiety disorder (ICD-10 criteria, assessment by the treating psychologists/doctors)
• No consent to participate in study (informed consent)
• No previous inpatient- or outpatient-treatment of at least one week
• No willingness to participate in Novego anxiety and four online assessments
• No ability to provide informed consent
• No sufficient understanding of the German language

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome parameter will be the Generalized Anxiety Disorder 7 Scale (GAD-7), a self-report questionnaire for the assessment of anxiety symptoms (T0, T1, T2, T3). Additionally, relapses will be analysed at T1, T2 and T3 and are defined as GAD-7 scores (1) > 8 (NHS, 2018) and (2) = 5 points more on the GAD-7 compared to the GAD-7 score at T0 (see Ali et al., 2017). <br><br>(T0 = a baseline assessment during the week before discharge, T1 = an interim assessment after 3 weeks, T2 = a post assessment 6 weeks after the baseline assessment, T3 = a follow-up assessment 3 more months after T2)